Findings

What do systematic reviews say?

11 questions · 11 findings · 1 reviews · Gut

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 18.2%GRADE not reported 0 · 0%Very low 4 · 36.4%Low 1 · 9.1%Moderate 4 · 36.4%High 0 · 0%

Web‐based disease monitoring vs sham monitoring

Disease activity · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Web‐based disease monitoring vs sham monitoring

Flare‐ups or relapse (continuous) · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Web‐based disease monitoring vs sham monitoring

Quality of life (adults) · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 447 participants
Very low

Web‐based disease monitoring vs usual care

Disease activity · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 428 participants
Moderate

Web‐based disease monitoring vs self‐screening

Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 102 participants
Very low

Web‐based disease monitoring vs self‐screening

Quality of life (adults) · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 102 participants
Very low

Web‐based disease monitoring vs usual care

Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease

Web‐based disease monitoring showed no clear difference in flare‐ups/relapse (dichotomous; adults) compared with usual care (moderate certainty).

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
RR 1.09 [0.93, 1.27]
5 studies · 868 participants
Moderate

Web‐based disease monitoring vs usual care

Flare‐ups or relapse (continuous) · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 909 participants
Moderate

Web‐based disease monitoring vs usual care

Flare‐ups/relapse (dichotomous; children) · people with inflammatory bowel disease

Web‐based disease monitoring showed no clear difference in flare‐ups/relapse (dichotomous; children) compared with usual care (low certainty).

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
RR 0.99 [0.65, 1.51]
1 study · 170 participants
Low

Web‐based disease monitoring vs usual care

Quality of life (adults) · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1099 participants
Moderate

Web‐based disease monitoring vs self‐screening

Disease activity · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 102 participants
Very low